RNS Number : 1042D
Deepverge PLC
23 October 2020

23 October 2020

DeepVerge PLC

("DeepVerge" or "the Company")

Reach Announcement

Comment on media coverage of detection of COVID-19 in UK Sewage


DeepVerge notes press commentary today that wastewater treatment sites in England, Wales and Scotland will start testing more sewage for coronavirus, with the aim of creating an early warning system to detect local outbreaks before they spread.

DeepVerge has been working with multiple universities and wastewater utilities since June this year on COVID-19 related projects. The Company is involved in many projects in the U.K., Ireland, Italy, Michigan, US, Shanghai, China and Japan.

Currently, in its Labskin laboratories in York, the Company is retrofitting Microtox equipment, from Modern Water plc (a company currently the subject of a recommended offer by DeepVerge) to install these projects.

Gerard Brandon CEO of DeepVerge Commented:

"The UK forms part of our COVID-19 real-time detection development strategy, cooperating with Modern Water plc supply chain and existing installation network in more than 60 countries. We continue to work with our EcoSystemOS consortium partners in the UK and overseas to bring advanced AI-based wastewater detection and pathogen identification projects from manual to automated real-time testing."

For further information please contact:

DeepVerge plc

Gerard Brandon, CEO


+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)


Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050


About DeepVerge plc (www.deepverge.com)

DeepVerge is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.

About Modern Water

Modern Water was established in 2006 to develop and commercialise water recovery technologies to counter water crisis problems arising from climate change and a growing global population. Having invested £20m over the last 14 years, the results comprise a robust patent portfolio of cutting-edge technology, focused on monitoring of contaminated water and decontamination of wastewater, making recycling of water more efficient. Six countries across the world have legislated that Modern Water monitoring test systems are written into their environmental protection legislation.

About EcoSystemOS (www.ecosystemOS.com)

Developed by the Rinocloud division of DeepVerge, this is a consortium of partners operating a live dynamic water management system that delivers safe clear water from rivers to wastewater treatment plants using Artificial Intelligence to provide instant alerts from remote sensors direct to stakeholders. It continuously evolves, learns and improves by bringing together multiple existing and smart technologies to create efficient water and deliver environmental protection. Over-the-air monitoring keeps stakeholders constantly up to date with web and mobile alert applications adapted for each group.

About Reach Announcements
Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. A Regulatory announcement is required to be notified under the AIM Rules for Companies.


This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.